Thank you so much David.
Best wishes
Graeme
Graeme.A Robertson
Senior Director, Africa & CIS
Access Operations & Emerging Markets
--------------------------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Europe Ltd . Registered as a limited company in England and Wales . Registered number 05510315
Registered office: South Building . 2 Roundwood Avenue . Stockley Park . Uxbridge . UB11 1AZ . England
Telephone: +44(0)208 587 2228 . Mobile: +44(0)7789 268 043 . Fax: +44(0)208 744 6773
-----Original Message-----
From: David Sergeenko [mailto:dsergeenko@moh.gov.ge]
Sent: 26 July 2017 17:54
To: Graeme Robertson; David Chitaia
Cc: Sopo Belkania
Subject: Re: Tbilisi, Georgia UGTB Business Contact
Dear Graeme
Please see requested info-
1. Contact Person- Mr. Mirian Sarishvili; 2. Title- General Director; 3. Company- "VIP Aviation Handling"; 4. Tbilisi International Airport, Tbilisi, Georgia.
5. Cell Phone: +995 599 511 922, Tel: +995 597 511 922, +995 790 511 922; 6. E-Mail: info@vipaviation.ge
Ops@vipaviation.ge
7. Web: www.vipaviation.ge
If you will need additional info, please feel free to contact me or Head of Ministry's office Mr. Sopo Belkania sbelkania@moh.gov.ge , +995 599 223
232
Kind Regards
David Sergeenko
On 7/26/17 4:30 AM, "Graeme Robertson" wrote:
>Dear Davit and David
>
>Would you be able to kindly provide the information requested below to
>assist in Dr John Martins travel to Tbilisi Thank you in advance for
>your help.
>
>Best wishes
>Graeme
>
>Sent from my iPhone
>
>Begin forwarded message:
>
>From: Angela Macedo
>>
>Date: 25 July 2017 at 22:44:42 CEST
>To: Graeme Robertson
>>
>Subject: Tbilisi, Georgia UGTB Business Contact
>
>Hi Graeme,
>
>For the trip to Tbilisi, we will need the following information in
>order to apply for the landing permit. If you would kindly provide the
>info requested below:
>
>Universal Handling needs a local business contact in to get the landing
>permit in Tbilisi.
>
>1) Name of contact
>2) Title if he or she has one
>3) Company Name
>4) Address to include city, country and zip code
>5) Phone number
>6) Fax number
>7) Email
>
>Thank you!
>Ang
>
>Angela Macedo | Executive Assistant to Gregg Alton, Executive Vice
>President, Corporate and Medical Affairs| Gilead Sciences, Inc. | 333
>Lakeside Drive | Foster City, CA 94404 | Phone: +1 650.522.6232 | Fax:
>+1
>650.577.6736 | e-mail:
>angela.macedo@gilead.com
>[cid:image001.png@01D2F650.639436C0]
>DISCLAIMER If you have received this message in error, please contact
>the sender immediately by return e-mail and notify the sender and then
>delete this message (including any attachments) from your system. This
>communication and any attachments contain information which is
>confidential and may also be legally privileged. It is for the
>exclusive use of the intended recipient(s). If you are not the intended
>recipient(s) please note that any form of disclosure, distribution,
>copying or use of this communication or the information in it or in any
>attachments is strictly prohibited and may be unlawful. E-mail
>communications cannot be guaranteed to be secure or error free, as
>information could be intercepted, corrupted, amended, lost, destroyed,
>arrive late or incomplete, or contain viruses. Gilead does not accept
>liability for any such matters or their consequences. Anyone who
>communicates with Gilead by e-mail is taken to accept the risks in
>doing so. Gilead has taken every reasonable precaution to ensure that
>any attachment to this e-mail has been swept for viruses. However,
>Gilead cannot accept liability for any damage sustained as a result of
>viruses and would advise that you carry out your own virus checks
>before opening any attachment. Gilead Sciences Europe Ltd ; Registered
>as a limited company in England and Wales ; Registered number 5510315
>Registered
>office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge
>;
>UB11 1AF ; England
DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England